Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders.

Slides:



Advertisements
Similar presentations
Overview of HPV vaccination Training GardasilTM
Advertisements

Supporting National e-Health Roadmaps WHO-ITU-WB joint effort WSIS C7 e-Health Facilitation Meeting 13 th May 2010 Hani Eskandar ICT Applications, ITU.
Development of the Consumer Professional Partnership Program (CPPP) Thilo Kroll NRH CHDR Steve Towle SCI Network RRTC on SCI: Promoting Health and Preventing.
Objectives  Review federal statutes (HIPAA, FERPA)  Discuss state guidelines  Review local procedures
1115 Waiver Kick-Off Meeting October 18, 2013 Office of the Governor, State of Illinois 1.
Issues Associated with Acceptability of Viral STD Vaccines Susan L. Rosenthal, Ph.D.
COUNTRY HEALTH PROFILE MYANMAR. NATIONAL HEALTH SYSTEM National Health Committee (NHC), the highest level policymaking body National Health Policy in.
Improving HPV Vaccination Coverage: Recent Activities Shannon Stokley National Center for Immunization and Respiratory Diseases February 18, 2014 National.
Child & Adolescent Health. Introduction What is it that you think of when you hear “Child & Adolescent Health”? What topics are of particular interest.
Chap 8: Adolescents, Young Adults, and Adults Instructor’s Name Semester, 200_.
Page 1 Understanding and Defining Issues  Any problem or potential problem facing an organization  Any controversial matter or disputed question affecting.
Orientation to the Health and Career Education K to 7 Integrated Resource Package 2006.
Global Health Program Guiding Principles April 2002.
U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES. National Standards for Culturally and Linguistically Appropriate Services in Health Care u Overview of OMH.
HEALTH EDUCATION Věra Kernová National Institute of Public Health Prague.
AIM 2030 Access to Innovative Medicines Draft concept for a new World Bank-led multi-stakeholder initiative August 2014, Andreas Seiter.
Meredith Carr, JD J. Stan Lehman, MPH David W. Purcell, JD, PhD Division of HIV/AIDS Prevention Centers for Disease Control and Prevention July 25, 2012.
National Policy Update—Parity, Healthcare Reform and Beyond Legal Action Center July 11, 2010.
Childhood TB Subgroup of the DEWG: update on policy recommendations Robert Gie Chairperson, Childhood TB Subgroup 31 October 2006 IUATLD Symposium: from.
Pan American Health Organization.. Protecting the Health of Health Care Workers: Experience from the Americas Marie-Claude Lavoie Decision Making for Using.
Program Collaboration and Service Integration: An NCHHSTP Green paper Kevin Fenton, M.D., Ph.D., F.F.P.H. Director National Center for HIV/AIDS, Viral.
Needs Assessment: Young People’s Drug and Alcohol Services in Edinburgh City EADP Children, Young People and Families Network Event 7 th March 2012 Joanne.
Multifaceted HPV Vaccination Strategies in California Achieving the Promise Avoiding the Pitfalls Heidi M. Bauer, MD MS MPH California Department of Public.
Antiviral Stockpiling for Novel Strains of Influenza.
Enhancing Communication Among Health Care and Educational Programs How Privacy Regulations Impact Delivery of Effective Services by Karl R. White National.
Public Health REPORT FROM PUBLIC HEALTH STAKEHOLDER GROUP Marty LaVenture and Mary Shaffran.
1 Manatt Health Solutions NYS Office of Health Information Technology Transformation Academy Health State Health Research and Policy Interest Group 2008.
THE NATIONAL INFLUENZA VACCINE SUMMIT: UPDATE Raymond A. Strikas, M.D. Immunization Services Division National Immunization Program Coordinating Center.
Stakeholder event – March 2012 You told us…. That you were concerned that prevention was not included in the service specification for this tender. Continuity.
Gustavo Aquino, MPH Associate Director for Program Integration National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Program Collaboration.
Social Pharmacy Lecture no. 6 Rational use of drugs Dr. Padma GM Rao
Chapter 4: Overview of the Health Care System Chapter Overview Chapter 4 is intended to provide a general understanding of how the health care system.
Influenza Vaccination Update for Jeanne M. Santoli, MD, MPH Deputy Director, Immunization Services Division National Center for Immunization and.
State Health Agency Perspectives on the Implementation of New Vaccines Presentation to the National Vaccine Advisory Committee September 26, 2006 Calvin.
State of California: Collaborative Efforts to Prepare for the HPV Vaccine Tammy Pilisuk, MPH Unit Chief, Provider Education CDHS Immunization Branch for.
Local Health Department Perspectives on HPV Vaccine Implementation Poki Stewart Namkung, MD, MPH President National Association of County & City Health.
Private Health Sector Assessments (PHSA) April Harding 2011.
Health Information Exchange Roadmap: The Landscape and a Path Forward Primary and Behavioral Health Care Integration Program Grantee.
Strengthening the Delivery of New Vaccines for Adolescents A National Stakeholders' Meeting Washington DC June 2-3, 2005.
Child & Adolescent Health. Introduction What is it that you think of when you hear “Child & Adolescent Health”? What topics are of particular interest.
1 Strategic Plan Review. 2 Process Planning and Evaluation Committee will be discussing 2 directions per meeting. October meeting- Finance and Governance.
Thorny Issues in HIV Vaccine Trials Saul Walker Policy Advisor IAVI.
1 Firearms and Suicide Prevention. 2 Objectives To understand suicide including The problem The risk factors Interventions Implementation issues Evaluation.
Planning for the Influenza Season National Vaccine Advisory Committee February 8, 2005 Washington, DC Lance E. Rodewald, MD Director, Immunization.
Joint Meeting of the Coverage and Future Vaccines Subcommittees October 5, 2004.
Health Reform: Is Your Community Ready for 2014? Frances M. Harding, Director SAMHSA’s Center for Substance Abuse Prevention 2011 School for Prevention.
NACDD Hill Day: Legislative Visits What to Expect Mari T. Brick, MA Program Consultant, NACDD
Implementing operational research for HIV treatment scale-up in resource-limited settings TB/HIV Research Priorities in Resource-Limited Settings Expert.
Delivery System Reform Incentive Payment Program (“DSRIP”) New York Presbyterian Performing Provider System.
Comprehensive School Health: (CSH) An Integrated Approach to Promoting Wellness in a Healthy School Setting.
Steps for the Integration of Traditional Medicine in the National Health Care Delivery System 18 TH ICASA Special Session on Traditional Medicine 1 st.
Nursing for School aged children and young people.
HIV testing guidance: know, treat, prevent Spotlight: HIV/AIDS European Centre for Disease Prevention and Control Stockholm, 1 December 2010.
Integration of Family Planning: Case Study in Manyara Region National Family Planning MCH/HIV Stakeholders Meeting Giraffe Hotel, Dar Es Salaam September.
NCHSE ANNUAL BOARD MEETING 1/27/16 Welcome!. Year in review since January 2015 Meeting…..
Darragh O’Loughlin MPSI IPU Secretary General Irish Pharmaceutical Healthcare Association RDS, Dublin: 26 November 2013.
Critical Program Movement: Integration of STD Prevention with Other Programs Kevin Fenton, MD, PhD, FFPH Director National Center for HIV/AIDS, Viral Hepatitis,
The Where & How of Reaching Adolescents: Adolescent Vaccination & Consent Abigail English, JD Center for Adolescent Health & the Law 41.
National Association of Hispanic Nurses
Chapter 6 The School Health Program: A Component of Community Health
HIV testing guidance: know, treat, prevent
Lecture 9: PHC As a Strategy For HP Dr J. Sitali
OHS Staff Introduction Training
Implementation Issues for HPV Vaccine
Gabrielle de la Guéronnière, Legal Action Center September 27, 2017
Increasing Adolescent Immunization Coverage
Collaborative Efforts in California to Prepare for the HPV Vaccine
Finance & Planning Committee of the San Francisco Health Commission
Potential Priority Handouts
March 8, 2006 New ACIP Hepatitis B Recommendations
Presentation transcript:

Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

Adolescent Stakeholders Meeting Provisional Goals  Identify the strengths and weaknesses of key implementation strategies and issues  Identify approaches that will effectively and efficiently increase the proportion of adolescents who receive vaccines  Develop plans to implement these approaches  Identify research initiatives – Support the successful introduction – Accelerate development of vaccines in the 'pipeline'

Adolescent Stakeholders Meeting Key Strategies and Issues A. Delivery systems and settings B. Integration with other adolescent health priorities C. Financing and other important barriers D. Consent E. Appropriate roles and responsibilities (local, state, and federal) F. Novel vaccine delivery systems G. Immunization regulations and other mandates H. Communications strategies

Adolescent Stakeholders Meeting Key Strategy/Issue A  In which combination of delivery systems and settings can the new adolescent vaccines best be implemented? – Primary health care providers – Non-traditional health care providers – Schools  Voluntary school based programs and  Vaccination as a requirement for school entry

Adolescent Stakeholders Meeting Key Strategy/Issue B  How can vaccination be integrated with other adolescent health priorities? – Prevention of unintentional injuries  Motor vehicle accidents – Prevention of intentional injuries  Homicide  Suicide – Prevention of drug and alcohol use

Adolescent Stakeholders Meeting Key Strategy/Issue C  How should vaccination efforts be financed?  Which other barriers at are most important to the health care system, providers, and patients? – e.g. missed opportunities, lack of knowledge (patients and providers)

Adolescent Stakeholders Meeting Key Strategy/Issue D  Are there new approaches to obtaining consent? – What laws enable minors to consent to treatment and prevention services in the U.S.? – What is the current and potential use of these laws to enable self-consent for adolescent immunization? – Can a single consent be flexible, e.g. covering multiple vaccinations with a single consent form?

Adolescent Stakeholders Meeting Key Strategy/Issue E  What are the appropriate roles and responsibilities of local, state, and federal public health officials? – Local  e.g. Should schools be involved? – State  e.g. Are mandates advisable? – Federal  e.g. Plan for national implementation?

Adolescent Stakeholders Meeting Key Strategy/Issue F  What is the role of novel vaccine delivery systems (i.e., needle-less systems) for delivery of vaccines to adolescents?

Adolescent Stakeholders Meeting Key Strategy/Issue G  When and how should immunization regulations and other mandates be used to increase the uptake of new vaccines? – Are mandates essential for equity? – What are the public health policy implications of recommendations in the absence of mandates? – Should there be federal guidance on what vaccines should be subject to mandates?  What laws best serve the public?  What is the appropriate role for pharmaceutical companies?

Adolescent Stakeholders Meeting Key Strategy/Issue H  What communications strategies are most appropriate and effective? – How should parents be informed?  Direct to consumer marketing?  Providers?  Physicians?

Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

Adolescent Stakeholders Meeting Venues, Duration, and Dates  Washington, DC  Dates (2 day periods) – March 14-15, 15-16, 16-17, – May 12-13, 18-19, – June 1-2, 2-3, 3-4, 20-21, 21-22, 22-23, , 27-28

Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.)

Adolescent Stakeholders Meeting Outline  Goals of meeting (5 min.)  Key strategies and issues (40 min.)  Venues, duration, and dates (10 min.)  Stakeholders (5 min.)  Organizing committee (10 min.) – Key strategies and issues – Vaccines  N. meningitidis conjugate  Tdap  HPV  HSV  CMV  HIV – Organization